S100A14 and esophageal squamous cell carcinoma: Exogenous S100A14 ligation with RAGE on ESCC cell lines reported that a low dosage of exogenous S100A14 activates ERK1/2 and NF-κB signaling, stimulating cell proliferation or increasing cell endurance, as shown in Figure 1A.